Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
21.72
Dollar change
+0.56
Percentage change
2.65
%
IndexRUT P/E- EPS (ttm)-1.02 Insider Own1.66% Shs Outstand75.07M Perf Week0.51%
Market Cap1.63B Forward P/E- EPS next Y-0.04 Insider Trans-0.80% Shs Float73.82M Perf Month-8.04%
Income-74.40M PEG- EPS next Q-0.16 Inst Own99.54% Short Float3.72% Perf Quarter-23.90%
Sales361.05M P/S4.52 EPS this Y74.74% Inst Trans0.36% Short Ratio4.37 Perf Half Y-3.81%
Book/sh14.25 P/B1.52 EPS next Y84.45% ROA-6.40% Short Interest2.74M Perf Year-0.87%
Cash/sh2.88 P/C7.53 EPS next 5Y- ROE-7.02% 52W Range19.52 - 30.52 Perf YTD-21.05%
Dividend Est.- P/FCF47.59 EPS past 5Y-10.52% ROI-7.08% 52W High-28.83% Beta1.62
Dividend TTM- Quick Ratio4.40 Sales past 5Y34.42% Gross Margin61.81% 52W Low11.27% ATR (14)0.91
Dividend Ex-Date- Current Ratio4.66 EPS Y/Y TTM-99.73% Oper. Margin-3.22% RSI (14)42.20 Volatility3.26% 3.72%
Employees815 Debt/Eq0.01 Sales Y/Y TTM21.76% Profit Margin-20.61% Recom1.89 Target Price31.67
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q-623.36% Payout- Rel Volume0.86 Prev Close21.16
Sales Surprise6.77% EPS Surprise-288.45% Sales Q/Q22.29% EarningsFeb 22 AMC Avg Volume627.70K Price21.72
SMA20-2.32% SMA50-9.60% SMA200-12.70% Trades Volume538,875 Change2.65%
Date Action Analyst Rating Change Price Target Change
Feb-23-24Reiterated Needham Buy $30 → $33
Jan-18-23Downgrade Raymond James Outperform → Mkt Perform
Jan-05-23Initiated Scotiabank Sector Outperform $33
Jan-07-22Initiated Stephens Overweight $52
Nov-18-21Resumed Goldman Buy $60
Jun-15-21Initiated Raymond James Outperform $45
Feb-18-21Resumed Needham Buy $88
Jan-28-21Initiated Truist Buy $61
Nov-10-20Initiated KeyBanc Capital Markets Sector Weight $48
Sep-09-20Initiated Morgan Stanley Underweight $35
Feb-27-24 05:55PM
Feb-26-24 03:20PM
Feb-23-24 11:10AM
07:43AM
07:37AM
06:05PM Loading…
Feb-22-24 06:05PM
05:03PM
04:40PM
04:05PM
Feb-21-24 05:00PM
Feb-08-24 08:00AM
Feb-06-24 08:15AM
Jan-08-24 08:00AM
Dec-12-23 04:30PM
Dec-01-23 04:05PM
08:30AM Loading…
Nov-29-23 08:30AM
Nov-22-23 08:30AM
Nov-08-23 04:39PM
Nov-07-23 04:57PM
04:05PM
04:00PM
Nov-02-23 08:15AM
Oct-27-23 08:30AM
Oct-26-23 02:50PM
Oct-17-23 08:15AM
Oct-16-23 10:43AM
Oct-12-23 09:00AM
Oct-04-23 04:05PM
Sep-28-23 04:05PM
08:15AM
09:00AM Loading…
Sep-27-23 09:00AM
Sep-21-23 04:05PM
Sep-07-23 04:05PM
Sep-06-23 08:15AM
Sep-02-23 06:15AM
Aug-29-23 08:15AM
Aug-22-23 08:15AM
Aug-15-23 04:15PM
Aug-08-23 06:05PM
04:55PM
04:05PM
Aug-01-23 08:15AM
Jul-19-23 05:00PM
Jul-08-23 08:43PM
Jun-20-23 08:31AM
Jun-12-23 08:31AM
May-30-23 06:56AM
May-25-23 05:13PM
May-24-23 09:00AM
May-23-23 05:00PM
May-22-23 07:30AM
May-12-23 06:15AM
May-05-23 01:59PM
May-04-23 06:25PM
04:05PM
09:45AM
May-03-23 05:44PM
08:30AM
May-02-23 04:05PM
May-01-23 05:35PM
Apr-29-23 04:31PM
Apr-27-23 04:05PM
10:02AM
09:55AM
Apr-18-23 09:48AM
Apr-17-23 08:30AM
Apr-13-23 05:00PM
Apr-12-23 08:30AM
Mar-23-23 06:54AM
Mar-15-23 04:15PM
11:44AM
Mar-11-23 12:11PM
Mar-10-23 09:30AM
Feb-27-23 05:00PM
Feb-24-23 05:42AM
Feb-22-23 06:15PM
04:05PM
Feb-15-23 08:36AM
Feb-13-23 05:23PM
10:14AM
Feb-06-23 05:00PM
Feb-01-23 04:05PM
08:32AM
Jan-24-23 10:23AM
Jan-23-23 09:00AM
Jan-18-23 06:10AM
Dec-22-22 08:54AM
Dec-21-22 09:08AM
Dec-15-22 04:05PM
Dec-12-22 12:00PM
Dec-01-22 02:46PM
Nov-09-22 06:15AM
Nov-02-22 06:55PM
04:05PM
Nov-01-22 05:11PM
Oct-27-22 05:00PM
Oct-25-22 08:30AM
Oct-24-22 08:30AM
Oct-18-22 04:05PM
Oct-17-22 01:58PM
Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
JONES EVAN/ FADirectorMar 01 '24Option Exercise13.1910,000131,90047,601Mar 05 05:28 PM
JONES EVAN/ FADirectorMar 01 '24Sale24.3610,000243,59937,601Mar 05 05:28 PM
JONES EVAN/ FADirectorJul 19 '23Sale30.173,09093,23235,173Jul 24 05:06 PM
JONES EVAN/ FADirectorJul 19 '23Sale30.1483825,25737,601Jul 24 05:06 PM
BISHOP JOHN LDirectorJul 18 '23Option Exercise6.3710,00063,70043,125Jul 19 08:35 PM
BISHOP JOHN LDirectorJul 18 '23Sale30.5010,000305,00033,125Jul 19 08:35 PM
JONES EVAN/ FADirectorJul 18 '23Sale30.197,441224,61638,263Jul 19 08:33 PM
JONES EVAN/ FADirectorJul 18 '23Sale30.162,32470,09038,439Jul 19 08:33 PM
BISHOP JOHN LDirectorJul 17 '23Option Exercise6.3710,00063,70043,125Jul 19 08:35 PM
JONES EVAN/ FADirectorJul 17 '23Sale30.0723,949720,10645,704Jul 19 08:33 PM
JONES EVAN/ FADirectorJul 17 '23Sale30.0719,095574,10640,763Jul 19 08:33 PM
BISHOP JOHN LDirectorJul 17 '23Sale30.0010,000300,00233,125Jul 19 08:35 PM
Bhanji MunaDirectorJun 16 '23Sale26.445,893155,78628,514Jun 21 04:55 PM
Bhanji MunaDirectorMay 30 '23Sale25.911,53939,87524,733Jun 01 05:06 PM
Anderson Bonnie HDirectorApr 14 '23Option Exercise5.6134,000190,74076,681Apr 18 04:44 PM
Anderson Bonnie HDirectorApr 14 '23Sale22.0434,000749,35742,681Apr 18 04:44 PM